000			02799nam a22003975c 4500
710	2		_aSpringerLink (Online service) _9106996
999			_c112420 _d112420 _x1
001			112420
003			ES-MaUEC
005			20230102113527.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			181230s2019 gw a s |||| 0|eng d
020			_a9783319997162
024	7		_a10.1007/978-3-319-99716-2 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC280 .L9 _bT34 2019
245	0	0	_aT-Cell and NK-Cell Lymphomas : _bFrom Biology to Novel Therapies _cedited by Christiane Querfeld, Jasmine Zain, Steven T. Rosen
264		1	_aCham _bSpringer International Publishing _c2019
300			_aVIII, 287 páginas _bilustraciones
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	1		_aCancer Treatment and Research _x0927-3042 _v176
490	0		_aMedicine (Springer-11650)
505	0		_aEpidemiology and Pathology of T cell lymphomas/NK cell lymphomas -- Molecular and genomic landscape -- Microenvironment -- PTCL, NOS -- AITL -- ALCL -- Adult T cell leukemia/lymphoma -- NK Cell lymphomas -- Hepatosplenic T cell lymphoma -- Rare subtypes e.g. gamma-delta T cell lymphoma -- Mycosis fungoides/Sézary syndrome -- CD30+ Lymphoproliferative disorders -- Transplantation. .
520	3		_aIn this book, a group of internationally distinguished lymphoma experts provide a comprehensive review of the most important advances in the biology, diagnosis, and therapy of T cell and NK cell malignancies. In particular, it demonstrates in detail how advances in our understanding of the tumor microenvironment and molecular biology have helped to elucidate the pathogenesis of these lymphomas, improve diagnostic and prognostic accuracy, and develop novel therapies that promise improved patient outcomes. Individual chapters are devoted to particular tumor types and subtypes, and all aspects of transplantation for patients with T cell and NK cell lymphomas are discussed. As such, the book offers a valuable resource for hematologists, oncologists, hematopathologists, and all those seeking an up-to-date overview of how new, targeted therapies are delivering better disease control and improved quality of life.
988			_aSpringer_Medicine_2019
650		7	_aLinfomas _2embne _9668066
650		7	_aOncología _2embne _9139207
776	0	8	_iPrinted edition: _z9783319997155
776	0	8	_iPrinted edition: _z9783319997179
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-99716-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_dz _feng _ggw _h0 _b07/2019 _eh _zSI